Description

Barcimiant (Baricitinib) 4 mg is a pharmaceutical product in the form of film-coated tablets.

Each tablet contains 4 mg of baricitinib, an active substance used in specialized medical practice.

⭐ Key Product Information

✔ Dosage form: film-coated tablets
✔ Active ingredient: baricitinib
✔ Strength: 4 mg
✔ Pack size: 28 tablets
✔ Country of manufacture: Egypt
✔ Category: pharmaceutical products

⭐ Use in Clinical Practice

The medicine is used as monotherapy or in combination with other medicinal products as part of a comprehensive treatment approach for rheumatoid arthritis in adult patients.

Barcimiant is prescribed in cases where previous therapy, including one or more tumor necrosis factor (TNF) inhibitors, has not produced an adequate clinical response.

🟦 Rheumatoid arthritis is a condition in which the immune system attacks the body’s own joints, which may lead to pain, swelling, and impaired joint function.

⭐ Mechanism of Action

The therapeutic effect of the medicine is based on reducing immune system activity, which helps control inflammatory processes within the treatment regimen prescribed by a physician.

❗ Important Information

The decision to use this medicine should be made jointly by the patient and the treating physician.

⭐ Allergic Reactions and Precautions

❗ Inform your doctor if you have ever experienced:

• allergic reactions to baricitinib or other medicines
• hypersensitivity to foods, colorants, or preservatives
• allergies to animals or other external factors

⭐ Additional Information

🔹 This medicine is a prescription-only product
🔹 Use strictly according to a doctor’s prescription
🔹 The information provided is for reference purposes only
🔹 It is not a substitute for professional medical advice